Newsfeeds - Spark Newswire

4 minute read

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

March 27, 4:40 PM

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

ADMP

7 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

March 24, 2:20 PM

On Thursday, 112 stocks made new 52-week lows.

ABCB

2 minute read

Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Crude Oil Up 1%

By Lisa Levin

March 18, 2:39 PM

U.S. stocks traded higher toward the end of trading, with the Nasdaq gaining 200 points on Friday.

AMBC

3 minute read

45 Stocks Moving In Friday’s Mid-Day Session

By Lisa Levin

March 18, 12:18 PM

Gainers Grom Social Enterprises, Inc. (NASDAQ: GROM) jumped 62.4% to $1.5500. DiDi Global Inc. (NYSE: DIDI) shares climbed 46% to $3.73.

AMBC

2 minute read

Mid-Morning Market Update: Markets Mixed; US Existing Home Sales Fall 7.2%

By Lisa Levin

March 18, 10:11 AM

U.S. stocks opened on a mixed note this morning, with the Dow Jones dropping more than 150 points on Friday.

AMBC

32 minute read

Stocks That Hit 52-Week Lows On Monday

By Benzinga Insights

March 7, 1:59 PM

On Monday, 524 stocks hit new 52-week lows.

AAL

22 minute read

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

March 4, 1:27 PM

On Friday, 368 stocks hit new 52-week lows.

AAL

30 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

February 22, 2:19 PM

During Tuesday's trading, 505 companies set new 52-week lows.

ACRX

1 minute read

Craig-Hallum Upgrades HTG Molecular Diagnostics to Buy, Raises Price Target to $8

By Benzinga Newsdesk

January 7, 11:17 AM

Craig-Hallum analyst Alexander Nowak upgrades HTG Molecular Diagnostics (NASDAQ:HTGM) from Hold to Buy and raises the price target from $5 to $8.

HTGM

4 minute read

51 Biggest Movers From Yesterday

By Lisa Levin

December 28, 5:23 AM

Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY robotic system for neurovascular applications.

AERI